Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.

Drug development research - 1 Aug 2020

Maffioletti Elisabetta, Gennarelli Massimo, Magri Chiara, Bocchio-Chiavetto Luisella, Bortolomasi Marco, Bonvicini Cristian, Abate Maria, Trabucchi Luigi, Ulivi Sheila, Minelli Alessandra

Abstract excerpt

Alterations in peripheral vascular endothelial growth factor (VEGF) levels were observed in major depressive disorder and relative treatments and were shown to be influenced by genetic variants. The study objective was to explore, at a genome-wide level, possible interplaying effects between the genetic background and major depressive disorder in regulating VEGF levels. Moreover, we aimed to investigate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Genotype

Share to Polymorphism, Single Nucleotide

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 32173896
DOI: 10.1002/ddr.21658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.PMID 32173896Read ↗

VEGF-related polymorphisms identified by GWAS and risk for major depression.Semantic proximity Read ↗

The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with DepressionSemantic proximity Read ↗

Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder.Semantic proximity Read ↗

Depression and BMI influences the serum vascular endothelial growth factor level.Semantic proximity Read ↗

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.Semantic proximity Read ↗

Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.Semantic proximity Read ↗

Peripheral blood micro RNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depressionSemantic proximity Read ↗

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development.Semantic proximity Read ↗

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder.Semantic proximity Read ↗

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)Semantic proximity Read ↗

Circulating NEGR1 Protein Levels Associate with Symptom Severity in Drug-Naïve Major Depressive DisorderSemantic proximity Read ↗

Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.